Moreover, we applied an immunofluorescence staining analysis of Ki67 to tumor tissue sections, demonstrating a much higher percentage of Ki67 positive cells in the MS tumors, compared to NC (Fig. 3l, m). This evidence concerns the gene MKI67 and myeloid sarcoma.